JTC-801

CAS No. 244218-51-7

JTC-801( —— )

Catalog No. M18298 CAS No. 244218-51-7

JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, weakly inhibits receptors δ, κ, and μ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 Get Quote
10MG 59 Get Quote
25MG 130 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JTC-801
  • Note
    Research use only, not for human use.
  • Brief Description
    JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, weakly inhibits receptors δ, κ, and μ.
  • Description
    JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, weakly inhibits receptors δ, κ, and μ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Opioid receptor-like1 (ORL1)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    244218-51-7
  • Formula Weight
    447.96
  • Molecular Formula
    C26H25N3O2·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : ≥ 0.33 mg/mL; 0.74 mM
  • SMILES
    Cl.CCC1=CC=C(OCC2=CC=CC=C2C(=O)NC2=CC3=C(C=C2)N=C(C)C=C3N)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yamada H, et al. Br J Pharmacol, 2002, 135(2), 323-332.
molnova catalog
related products
  • N-Benzylpalmitamide

    N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.

  • NRX-252262

    NRX-252262 is a potent enhancer of the interaction between β-Catenin, and its cognate E3 ligase, SCFβ-TrCP, induces mutant β-catenin degradation(EC50:3.8 nM)

  • C-Peptide, dog

    C-Peptide, dog is a component of proinsulin, released from pancreatic beta cells into blood together with insulin. The C-peptide of proinsulin is important for the biosynthesis of insulin but has for a long time been considered to be biologically inert.